yesterday's down day was not for a very sensible reason. It was because of the company's exposure to Ireland...a la Brexit.
don't know but these mid cap biotechs are very volatile. rumor floating around that Sanofi may make a bid if they don't buy Medivation. But who really knows?
nice post. we need more smart, logical people like you. way to go.
thank you dil for being alive when the rest of this board is fast asleep. I did not buy more today as this drop might go on a bit more. but I will be watching.
looks to me the end of selling can go a ways. this stock could see 190 if this selling gets in high gear.
not really. tecfidera, which accounts for 95% of their revenue, is slowing and a lot of hope fora new MS drug was hanging on Lingo 1. this is a bummer. and with tecfidera going generic sooner rather than later, that spells trouble. many of their drugs to reinvigorate growth are in early stages. Biib either gets acquired, acquires someone and at the same time, faces significant downside pressure because of what I mentioned here. don't just think that selling is overdone. could be trouble ahead.